Virtual versus in-person sexual rehabilitation for prostate cancer survivors: a retrospective cohort study comparing the Prostate Cancer Rehabilitation Clinic (PCRC) and the True North Sexual Health and Rehabilitation eClinic (SHAReClinic).

IF 2.4 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL
Sexual Medicine Pub Date : 2025-11-06 eCollection Date: 2025-10-01 DOI:10.1093/sexmed/qfaf088
Andrew G Matthew, Steven Guirguis, Taylor Incze, Dalia Peres, Richard J Wassersug, Lauren Walker, John W Robinson, Deborah McLeod, Stacy Elliott, Antionio Finelli, Neil Fleshner, Leah Jamnicky, Shiyi Chen, Dean Elterman
{"title":"Virtual versus in-person sexual rehabilitation for prostate cancer survivors: a retrospective cohort study comparing the Prostate Cancer Rehabilitation Clinic (PCRC) and the True North Sexual Health and Rehabilitation eClinic (SHAReClinic).","authors":"Andrew G Matthew, Steven Guirguis, Taylor Incze, Dalia Peres, Richard J Wassersug, Lauren Walker, John W Robinson, Deborah McLeod, Stacy Elliott, Antionio Finelli, Neil Fleshner, Leah Jamnicky, Shiyi Chen, Dean Elterman","doi":"10.1093/sexmed/qfaf088","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Sexual dysfunction is a common and distressing consequence of prostate cancer (PCa) treatment, yet few healthcare institutions offer comprehensive, systematic care, limiting equitable access. Virtual models may improve accessibility and efficiency without sacrificing effectiveness.</p><p><strong>Aim: </strong>To assess whether outcomes in the virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) were comparable to those in the in-person Prostate Cancer Rehabilitation Clinic (PCRC) in improving sexual health outcomes for PCa survivors.</p><p><strong>Methods: </strong>A retrospective cohort chart review was conducted on PCa patients enrolled in either the PCRC or SHAReClinic between September 2017 and August 2018, with data collected 12 months post-treatment. Clinic assignment was based on standard care pathways. Sexual health outcomes were measured using the Sexual Health Inventory for Men (SHIM), Sexual Distress Scale (SDS), Male Sexual Health Questionnaire (MSIS), and Expanded Prostate Cancer Index Composite (EPIC-26). Pro-erectile medication usage was also analyzed.</p><p><strong>Outcomes: </strong>Primary outcomes were SHIM and SDS scores. Secondary outcomes included MSIS, EPIC-26 scores, and pro-erectile medication use as an indicator for adherence and ongoing sexual activity.</p><p><strong>Results: </strong>Among 98 PCa patients (55 PCRC, 43 SHAReClinic), no significant differences were found in SHIM and SDS scores. While partnered PCRC participants reported significantly higher intimacy on the MSIS compared to partnered SHAReClinic participants (<i>P</i> = .042), no significant differences were found on the EPIC-26 sexual health domain. Pro-erectile medication use was similar in both groups. Multivariable analyses showed comparable outcomes in sexual function, distress, and health-related quality of life, except for intimacy.</p><p><strong>Clinical implications: </strong>SHAReClinic yields comparable outcomes to PCRC and provides an effective, resource-efficient alternative to in-person sexual rehabilitation for PCa patients, particularly in settings with limited accessibility or resources.</p><p><strong>Strengths and limitations: </strong>This study provides a comprehensive assessment of sexual health outcomes; however, the small sample size limits generalizability. In addition, there was a significant imbalance in treatment modality, with radiation patients represented only in the SHAReClinic cohort. Further research in larger, more diverse populations with longer follow-up is needed to confirm these findings and better understand intimacy differences.</p><p><strong>Conclusion: </strong>SHAReClinic demonstrates outcomes comparable to PCRC in managing sexual dysfunction in PCa patients, offering a viable and accessible option for sexual rehabilitation.</p>","PeriodicalId":21782,"journal":{"name":"Sexual Medicine","volume":"13 5","pages":"qfaf088"},"PeriodicalIF":2.4000,"publicationDate":"2025-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12596167/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Sexual Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/sexmed/qfaf088","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Sexual dysfunction is a common and distressing consequence of prostate cancer (PCa) treatment, yet few healthcare institutions offer comprehensive, systematic care, limiting equitable access. Virtual models may improve accessibility and efficiency without sacrificing effectiveness.

Aim: To assess whether outcomes in the virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) were comparable to those in the in-person Prostate Cancer Rehabilitation Clinic (PCRC) in improving sexual health outcomes for PCa survivors.

Methods: A retrospective cohort chart review was conducted on PCa patients enrolled in either the PCRC or SHAReClinic between September 2017 and August 2018, with data collected 12 months post-treatment. Clinic assignment was based on standard care pathways. Sexual health outcomes were measured using the Sexual Health Inventory for Men (SHIM), Sexual Distress Scale (SDS), Male Sexual Health Questionnaire (MSIS), and Expanded Prostate Cancer Index Composite (EPIC-26). Pro-erectile medication usage was also analyzed.

Outcomes: Primary outcomes were SHIM and SDS scores. Secondary outcomes included MSIS, EPIC-26 scores, and pro-erectile medication use as an indicator for adherence and ongoing sexual activity.

Results: Among 98 PCa patients (55 PCRC, 43 SHAReClinic), no significant differences were found in SHIM and SDS scores. While partnered PCRC participants reported significantly higher intimacy on the MSIS compared to partnered SHAReClinic participants (P = .042), no significant differences were found on the EPIC-26 sexual health domain. Pro-erectile medication use was similar in both groups. Multivariable analyses showed comparable outcomes in sexual function, distress, and health-related quality of life, except for intimacy.

Clinical implications: SHAReClinic yields comparable outcomes to PCRC and provides an effective, resource-efficient alternative to in-person sexual rehabilitation for PCa patients, particularly in settings with limited accessibility or resources.

Strengths and limitations: This study provides a comprehensive assessment of sexual health outcomes; however, the small sample size limits generalizability. In addition, there was a significant imbalance in treatment modality, with radiation patients represented only in the SHAReClinic cohort. Further research in larger, more diverse populations with longer follow-up is needed to confirm these findings and better understand intimacy differences.

Conclusion: SHAReClinic demonstrates outcomes comparable to PCRC in managing sexual dysfunction in PCa patients, offering a viable and accessible option for sexual rehabilitation.

Abstract Image

Abstract Image

Abstract Image

前列腺癌幸存者的虚拟与面对面性康复:一项回顾性队列研究,比较前列腺癌康复诊所(PCRC)和真北性健康与康复诊所(SHAReClinic)。
背景:性功能障碍是前列腺癌(PCa)治疗的常见和令人痛苦的后果,但很少有医疗机构提供全面,系统的护理,限制了公平获取。虚拟模型可以在不牺牲有效性的情况下提高可访问性和效率。目的:评估虚拟性健康和康复诊所(SHAReClinic)在改善前列腺癌幸存者性健康结果方面是否与面对面的前列腺癌康复诊所(PCRC)相当。方法:对2017年9月至2018年8月在PCRC或SHAReClinic登记的PCa患者进行回顾性队列图回顾,数据收集于治疗后12个月。临床分配基于标准护理途径。采用男性性健康量表(SHIM)、性困扰量表(SDS)、男性性健康问卷(MSIS)和扩展前列腺癌指数综合量表(EPIC-26)对性健康结果进行测量。还分析了促勃起药物的使用情况。结果:主要结果为SHIM和SDS评分。次要结果包括MSIS、EPIC-26评分和促勃起药物使用作为依从性和持续性活动的指标。结果:98例PCa患者(55例PCRC, 43例SHAReClinic), SHIM和SDS评分无显著差异。与SHAReClinic合作的参与者相比,PCRC合作的参与者在MSIS上报告了更高的亲密度(P =。042),在EPIC-26性健康领域没有发现显著差异。两组的促勃起药物使用情况相似。多变量分析显示,除亲密关系外,性功能、痛苦和健康相关生活质量的结果具有可比性。临床意义:SHAReClinic的结果与PCRC相当,并为PCa患者提供了一种有效的、资源高效的替代方案,特别是在可及性或资源有限的环境中。优势和局限性:本研究对性健康结果进行了全面评估;然而,小样本量限制了普遍性。此外,在治疗方式上存在显著的不平衡,仅在SHAReClinic队列中有放疗患者。需要在更大、更多样化的人群中进行进一步的研究,并进行更长时间的随访,以证实这些发现,并更好地了解亲密关系的差异。结论:SHAReClinic在治疗前列腺癌患者的性功能障碍方面显示了与PCRC相当的结果,为性康复提供了一个可行的和可获得的选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Sexual Medicine
Sexual Medicine MEDICINE, GENERAL & INTERNAL-
CiteScore
5.40
自引率
0.00%
发文量
103
审稿时长
22 weeks
期刊介绍: Sexual Medicine is an official publication of the International Society for Sexual Medicine, and serves the field as the peer-reviewed, open access journal for rapid dissemination of multidisciplinary clinical and basic research in all areas of global sexual medicine, and particularly acts as a venue for topics of regional or sub-specialty interest. The journal is focused on issues in clinical medicine and epidemiology but also publishes basic science papers with particular relevance to specific populations. Sexual Medicine offers clinicians and researchers a rapid route to publication and the opportunity to publish in a broadly distributed and highly visible global forum. The journal publishes high quality articles from all over the world and actively seeks submissions from countries with expanding sexual medicine communities. Sexual Medicine relies on the same expert panel of editors and reviewers as The Journal of Sexual Medicine and Sexual Medicine Reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书